ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,713 | -8.7% | 1,711 | +2.5% | 0.00% | – |
| Q2 2023 | $47,888 | +10.6% | 1,670 | -7.5% | 0.00% | – |
| Q1 2023 | $43,282 | +31.2% | 1,806 | -8.8% | 0.00% | – |
| Q4 2022 | $33,000 | 0.0% | 1,981 | -14.4% | 0.00% | – |
| Q3 2022 | $33,000 | -10.8% | 2,313 | -5.6% | 0.00% | – |
| Q2 2022 | $37,000 | -45.6% | 2,451 | -2.8% | 0.00% | – |
| Q1 2022 | $68,000 | -41.4% | 2,521 | -19.4% | 0.00% | – |
| Q4 2021 | $116,000 | -39.3% | 3,127 | -21.8% | 0.00% | – |
| Q3 2021 | $191,000 | +26.5% | 3,998 | -10.9% | 0.00% | – |
| Q2 2021 | $151,000 | -85.6% | 4,485 | -82.3% | 0.00% | -100.0% |
| Q1 2021 | $1,045,000 | +400.0% | 25,331 | +425.2% | 0.00% | +200.0% |
| Q4 2020 | $209,000 | +62.0% | 4,823 | +60.2% | 0.00% | – |
| Q3 2020 | $129,000 | +57.3% | 3,010 | +72.3% | 0.00% | – |
| Q2 2020 | $82,000 | +925.0% | 1,747 | +191.2% | 0.00% | – |
| Q1 2020 | $8,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |